SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins-Reference-Cited by-同舟云学术

SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins

Published:2018-06 Issue: Volume:154 Page:233-252
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Yan Su,Elmes Matthew W.,Tong Simon,Hu Kongzhen,Awwa Monaf,Teng Gary Y.H.,Jing Yunrong,Freitag Matthew,Gan Qianwen,Clement Timothy,Wei Longfei,Sweeney Joseph M.,Joseph Olivia M.,Che Joyce,Carbonetti Gregory S.,Wang Liqun,Bogdan Diane M.,Falcone Jerome,Smietalo Norbert,Zhou Yuchen,Ralph Brian,Hsu Hao-Chi,Li Huilin,Rizzo Robert C.,Deutsch Dale G.,Kaczocha Martin^ORCID,Ojima Iwao^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference48 articles.

1. Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors;Kaczocha;J. Biol. Chem.,2012

2. Fatty acid-binding proteins (FABPs) are intracellular carriers for Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD);Elmes;J. Biol. Chem.,2015

3. A personal retrospective: elevating anandamide (AEA) by targeting fatty acid amide hydrolase (FAAH) and the fatty acid binding proteins (FABPs);Deutsch;Front. Pharmacology (Basel),2016

4. Identification of intracellular carriers for the endocannabinoid anandamide;Kaczocha;Proc. Natl. Acad. Sci. Unit. States Am.,2009

5. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia;Lichtman;Pain,2004

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential safety implications of fatty acid-binding protein inhibition;Toxicology and Applied Pharmacology;2024-10

2. ART26.12, a novel fatty acid‐binding protein 5 inhibitor, shows efficacy in multiple preclinical neuropathy models;European Journal of Pain;2024-08-26

3. Discovery and Preclinical Evaluation of a Novel Inhibitor of FABP5, ART26.12, Effective in Oxaliplatin-Induced Peripheral Neuropathy;The Journal of Pain;2024-07

4. Recent Advances on Small-Molecule Inhibitors of Lipocalin-like Proteins;Journal of Medicinal Chemistry;2024-03-25

5. Quantum biochemical analysis of the binding interactions between a potential inhibitory drug and the Ebola viral glycoprotein;Journal of Biomolecular Structure and Dynamics;2024-01-23